Please assess the completion status of the following clinical trial:

Trial Title: TAP Block for Open Radical Prostatectomy.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 18 years and over~* ASA class 1, 2~* Elective open radical prostatectomy~Exclusion Criteria:~* Any history or signs of cardiac, hepatic and renal failure. Patients with raised serum LFTs and serum creatinine outside normal range~* Any chronic use of opioid analgesic~* Morbid obesity (BMI\>40)~* History of allergic reactions to any of the study medications and the medications used for the trial~* Pregnancy~* Previous abdominal surgery

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: PLACEBO_COMPARATOR): group A (control) will receive a bolus of normal saline (20 mL per side) followed by a continuous infusion of normal saline (7 ml/h per side) via both TAP catheters.The infusions will be started after the bolus doses and continued postoperatively for 48 hours.
- TAP (Type: EXPERIMENTAL): group B (TAP) will receive a bolus of lidocaine 1% with epinephrine 1:200 000 (20 mL per side) followed by a continuous infusion of ropivacaine 0.2% (7 mL/h per side) via TAP catheters. The infusions will be started after the bolus doses and continued postoperatively for 48 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).